Search Results
Dec 09, 2025, 11:57 ET Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Traditional pharmaceutical strategies are giving ground as breakthrough approvals for gene therapies and mRNA platforms target previously untreatable rare diseases with precision interventions[1]. Healthcare systems integrating AI diagnostic tools now match therapies to individual genetic profiles
More news about: Equity Insider
Dec 09, 2025, 11:00 ET Hammes Healthcare announces addition of Lisa Lieberman as Operational Readiness Executive
settings and led to measurable success in managing large-scale change."Lisa's expansive experience as a senior health system executive gives her a rare 360-degree perspective of what it takes to operationalize complex healthcare environments," said Liezl Diaz, Vice President, Hammes Healthcare. "Her
More news about: Hammes
Dec 09, 2025, 10:40 ET Accelerated Cure Project Appoints First Director of Marketing and Communications
global brand agencies Leo Burnett and Starcom, and The Walt Disney Company, where she began her career nearly 30 years ago."Cristal brings a rare combination of strategic vision, creative excellence, and deep mission alignment," said Sara Loud, CEO of Accelerated Cure Project. "Her leadership
More news about: Accelerated Cure Project for Multiple Sclerosis
Dec 09, 2025, 10:10 ET Celebrate the Holidays with Christian Siriano x Rare Carat
& CEO of Rare Carat. "Partnering with Christian brought a fresh creative lens to our platform—one that speaks to today's fashion-forward consumer while staying rooted in fine-jewelry integrity."This holiday season, the Christian Siriano x Rare Carat collection stands out as a rare fusion between
More news about: Rare Carat
Dec 09, 2025, 09:15 ET Former U.S. Attorneys Warn of Unprecedented Threat to America's Justice System at Speak Up for Justice Forum on December 15
LOS ANGELES, Dec. 9, 2025 /PRNewswire/ -- A rare bipartisan group of former U.S. Attorneys will convene on December 15 to warn about what they call an unprecedented threat to the independence of America's justice system.
More news about: Kiesel Law
Dec 09, 2025, 09:07 ET MedINT Launches First Human-in-the-Loop Medical AI Platform for Complex Clinical Decision-Making
ensures that AI-generated insights support, rather than shortcut, expert clinical reasoning.Complex cases often involve overlapping conditions, rare clinical profiles, and conflicting research, which complicates clinical interpretation. With more than 50% of U.S. adults reporting multiple chronic
More news about: Medint
Dec 09, 2025, 09:00 ET TrilliumBiO and Oncobit Partner to Bring Novel Uveal Melanoma Monitoring Solution to the U.S.
and progression, underscoring its value as a powerful prognostic tool in metastatic uveal melanoma.1,2,3"Drawing on our expertise in rare disease diagnostics, TrilliumBiO is proud to help bring a breakthrough solution for uveal melanoma to the U.S.," said Laura Vivian, CEO of TrilliumBiO.
More news about: TrilliumBiO
Dec 09, 2025, 09:00 ET Bazooka Brands™ Appoints David Dreyer as Chief Marketing Officer
into cultural powerhouses through bold thinking, breakthrough creativity, and a deep understanding of what moves modern consumers. "Dave is a rare combination of strategic leader, culture-maker, and business builder," said Tony Jacobs, President & CEO of Bazooka Brands™. "His ability
More news about: Bazooka Brands
Dec 09, 2025, 09:00 ET 99 RANCH MARKET UNVEILS EAT UP FOOD HALL, NYC'S LARGEST PAN-ASIAN FOOD DESTINATION
specialties like aromatic Guangxi rice noodles and Central Asian halal barbecue. Representing authentic cooking styles and traditions, the food hall offers a rare opportunity to experience the richness and depth of Pan-Asian culinary culture without leaving New York City.Beautiful, Spacious, and Created
More news about: 99 Ranch Market
Dec 09, 2025, 08:42 ET Mercury Bio Announces Appointment of Casey Perkins as Vice President of Corporate Strategy & Business Development
25 years of leadership in biotech and pharmaceuticals, covering commercial strategy, market access, channel operations, and patient services across rare and orphan diseases, as well as cell and gene therapies in neurology, oncology, and immunology. She previously supported commercialization of transformational
More news about: Mercury Bio Inc.
Dec 09, 2025, 08:41 ET Pediatric Associates Family of Companies Launches VaxFacts.info: A Trusted, Pediatrician-Reviewed Resource for Families Seeking Reliable Vaccine Information
preventable. Thanks to vaccines, diseases such as polio, measles, diphtheria, and whooping cough, which once caused widespread illness and death, are now rare or eliminated in the U.S."Vaccines are one of the most powerful tools in modern medicine," said Dr. Slonaker. "Our own pediatricians follow the
More news about: Pediatric Associates
Dec 09, 2025, 08:40 ET Wonder Sciences Brings 190 Global Leaders to Antarctica for a Landmark Summit on the Future of Mental Healthcare and Advanced AI
Antarctica's stark clarity and scale provided a rare setting for examining how the convergence of psychedelic science, precision psychiatry, and advanced AI can redefine global mental healthcare."Bringing
More news about: Wonder Sciences
Dec 09, 2025, 08:40 ET What American Drivers Really Want, and How VinFast Is Delivering It
when not.What emerges from these elements, long warranty coverage, transparent digital tools, and accessible after-sales support, is something rare for a young automaker: an ongoing relationship with the customer, rather than a one-time sale. It's a model built on trust, continuity, and practical
More news about: Vinfast Auto LLC
Dec 09, 2025, 08:38 ET Sen-Jam Pharmaceutical Appoints Global Life Sciences Leader Rute Fernandes as Executive Advisor to Accelerate Commercialization Pathways
regional, and country-level roles at organizations including Novartis, Shire, and Takeda. She has led high-impact initiatives spanning drug development, rare disease strategy, commercial operations, global launches, digital transformation, and large-scale integrations—managing P&Ls exceeding $2 billion
More news about: Sen-Jam Pharmaceutical
Dec 09, 2025, 08:33 ET Korea University Researchers Develop Ultrasensitive Method to Detect Low-Frequency Cancer Mutations
cleaves perfectly matched wild-type DNA, thereby enriching the relative proportion of circulating tumor DNA before sequencing. This enrichment allows rare variants to rise above the intrinsic noise that commonly limits next-generation sequencing. As Prof. Hur explains, "Our findings suggest that the
More news about: Korea University College of Medicine
Dec 09, 2025, 08:30 ET Pryzm Raises $12M Led by Andreessen Horowitz to Transform Federal Procurement with AI
runs on. You can feel that shift happening across startups, primes, and government teams," said Ross Fubini, Founder & Managing Partner, XYZ. "It's rare to see a company define a category this quickly in a space as complex as federal acquisition."For industry, Pryzm delivers real-time insights
More news about: Pryzm Dynamics Inc.
Dec 09, 2025, 08:00 ET AVAIO Digital Marks Major Milestone as CEC Approves 99MW for Bay Area Data Center Project Perseus
Situated in one of the nation's most supply-constrained data center markets, Project Perseus offers rare proximity to key Bay Area markets. The site is 35 miles to San Francisco and 45 miles to Silicon Valley hubs including Santa Clara, Sunnyvale, and Mountain
More news about: AVAIO Digital
Dec 09, 2025, 08:00 ET Lee's Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights
Hong Kong, Macau and Taiwan. The Company focuses on several key disease therapeutic areas such as cardiovascular health, woman's health, paediatrics, rare diseases, oncology, dermatology and obstetrics.More information available at www.leespharm.com.About
More news about: Lee's Pharmaceutical Holdings Limited
Dec 09, 2025, 08:00 ET Parks and WNP stores are open across the West: A big message from a small mammal
of me). Share the stories you learned. You never know who might be inspired to plan a trip, volunteer, or support a park. Treat parks like the rare privilege they are Pack it in, pack it out. Respect wildlife. Give everyone—two-legged, four-legged, winged and whiskered—the space they need. A
More news about: Western National Parks
Dec 09, 2025, 07:44 ET Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma
treatment discontinuation and were effectively managed using standard guidelines.1 Immune effector cell-associated neurotoxicity syndrome was rare and occurred in 1.1% of patients.1 Serious adverse events occurred in 70.7% of patients compared to 62.4% of patients treated with the control
More news about: Johnson & Johnson
Dec 09, 2025, 07:30 ET Recordati Rare Diseases Announces Real-World Data on Long-Term Safety of ENJAYMO® (sutimlimab-jome) in Cold Agglutinin Disease and Cold Agglutinin Syndrome (CAD/CAS) at American Society of Hematology (ASH) Annual Meeting
employees.Recordati Rare Diseases' mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis, and expand availability of treatments for people with rare diseases.Recordati
More news about: Raliance Communications
Dec 09, 2025, 07:30 ET Novel Agent Ianalumab Added to Standard Therapy Extends Time to Treatment Failure in Patients with Previously Treated Immune Thrombocytopenia
clotting. A normal platelet count is between 150,000 and 400,000 per microliter of blood; in patients with ITP, it's often less than 50,000. The disease is rare, affecting an estimated 50,000 people in the United States — women more frequently than men. Standard first-line treatment includes steroid medications
More news about: American Society of Hematology
Dec 09, 2025, 07:08 ET Rush University's Former Chair of Pain Medicine, Dr. Timothy Lubenow, Joins MAPS Centers for Pain Control to Expand Access to Advanced Pain Care in Chicago
Chicago."Thomas Pontinen, M.D., Co-Founder of MAPS, added: "Patients in our city deserve access to the very best. Dr. Lubenow brings the rare combination of deep clinical experience and a genuine commitment to patient outcomes."Dr. Lubenow will treat patients at MAPS' Chicago location,
More news about: MAPS Centers for Pain Control
Dec 09, 2025, 07:00 ET Cypherpunk Taps Zcash Founder Zooko as Strategic Advisor
CypherpunkCypherpunk is a company dedicated to privacy and self-sovereignty. As the world becomes increasingly digitized, privacy has become a rare and vanishing commodity. Despite this, privacy enhancing technologies remain under-adopted. Backing privacy today is both a generational mission and
More news about: Cypherpunk Technologies Inc.
Dec 09, 2025, 07:00 ET Cypherpunk Taps Zcash Founder Zooko as Strategic Advisor
CypherpunkCypherpunk is a company dedicated to privacy and self-sovereignty. As the world becomes increasingly digitized, privacy has become a rare and vanishing commodity. Despite this, privacy enhancing technologies remain under-adopted. Backing privacy today is both a generational mission and
More news about: Cypherpunk Technologies Inc.